Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

Kamble N, Netravathi M, Nagaraju BC, Lenka A, Kumar K, Sowmya V, Jain S, Pal PK.

Can J Neurol Sci. 2018 Mar;45(2):176-181. doi: 10.1017/cjn.2017.277. Epub 2018 Jan 8.

PMID:
29307324
2.

Cortical inhibitory deficits in premanifest and early Huntington's disease.

Philpott AL, Cummins TDR, Bailey NW, Churchyard A, Fitzgerald PB, Georgiou-Karistianis N.

Behav Brain Res. 2016 Jan 1;296:311-317. doi: 10.1016/j.bbr.2015.09.030. Epub 2015 Sep 28.

PMID:
26416671
3.

Abnormal intracortical facilitation in early-stage Huntington's disease.

Nardone R, Lochner P, Marth R, Ausserer H, Bratti A, Tezzon F.

Clin Neurophysiol. 2007 May;118(5):1149-54. Epub 2007 Mar 1.

PMID:
17336146
4.

Abnormal motor cortex excitability in preclinical and very early Huntington's disease.

Schippling S, Schneider SA, Bhatia KP, Münchau A, Rothwell JC, Tabrizi SJ, Orth M.

Biol Psychiatry. 2009 Jun 1;65(11):959-65. doi: 10.1016/j.biopsych.2008.12.026. Epub 2009 Feb 7.

5.

Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia.

Takahashi S, Ukai S, Kose A, Hashimoto T, Iwatani J, Okumura M, Tsuji T, Shinosaki K.

Schizophr Res. 2013 May;146(1-3):238-43. doi: 10.1016/j.schres.2013.02.033. Epub 2013 Mar 22.

PMID:
23523695
6.

Changes in thresholds for intracortical excitability in chronic stroke: more than just altered intracortical inhibition.

Edwards JD, Meehan SK, Linsdell MA, Borich MR, Anbarani K, Jones PW, Ferris J, Boyd LA.

Restor Neurol Neurosci. 2013;31(6):693-705. doi: 10.3233/RNN-120300.

PMID:
23963339
7.

Motor cortical excitability studied with repetitive transcranial magnetic stimulation in patients with Huntington's disease.

Lorenzano C, Dinapoli L, Gilio F, Suppa A, Bagnato S, Currà A, Inghilleri M, Berardelli A.

Clin Neurophysiol. 2006 Aug;117(8):1677-81. Epub 2006 Jun 21.

PMID:
16793338
8.

Noninvasive brain stimulation in Huntington's disease.

Berardelli A, Suppa A.

Handb Clin Neurol. 2013;116:555-60. doi: 10.1016/B978-0-444-53497-2.00044-9. Review.

PMID:
24112923
9.

Impairments in motor-cortical inhibitory networks across recent-onset and chronic schizophrenia: a cross-sectional TMS Study.

Strube W, Wobrock T, Bunse T, Palm U, Padberg F, Malchow B, Falkai P, Hasan A.

Behav Brain Res. 2014 May 1;264:17-25. doi: 10.1016/j.bbr.2014.01.041. Epub 2014 Feb 6.

PMID:
24509248
10.

Cortical excitability in drug naive juvenile myoclonic epilepsy.

Puri V, Sajan PM, Chowdhury V, Chaudhry N.

Seizure. 2013 Oct;22(8):662-9. doi: 10.1016/j.seizure.2013.05.001. Epub 2013 Jun 7.

11.

The effect of test TMS intensity on short-interval intracortical inhibition in different excitability states.

Garry MI, Thomson RH.

Exp Brain Res. 2009 Feb;193(2):267-74. doi: 10.1007/s00221-008-1620-5. Epub 2008 Oct 31.

PMID:
18974984
12.

Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients.

Rossi S, De Capua A, Tavanti M, Calossi S, Polizzotto NR, Mantovani A, Falzarano V, Bossini L, Passero S, Bartalini S, Ulivelli M.

Biol Psychiatry. 2009 Jul 1;66(1):54-61. doi: 10.1016/j.biopsych.2009.03.008. Epub 2009 Apr 15.

PMID:
19368897
13.

Normal cortical excitability in Myoclonus-Dystonia--a TMS study.

van der Salm SM, van Rootselaar AF, Foncke EM, Koelman JH, Bour LJ, Bhatia KP, Rothwell JC, Tijssen MA.

Exp Neurol. 2009 Apr;216(2):300-5. doi: 10.1016/j.expneurol.2008.12.001. Epub 2008 Dec 11.

PMID:
19118553
14.

Reduced motor cortical inhibition in migraine: A blinded transcranial magnetic stimulation study.

Neverdahl JP, Omland PM, Uglem M, Engstrøm M, Sand T.

Clin Neurophysiol. 2017 Dec;128(12):2411-2418. doi: 10.1016/j.clinph.2017.08.032. Epub 2017 Sep 22.

PMID:
29096214
15.

Reduced cortical inhibition in first-episode schizophrenia.

Wobrock T, Schneider M, Kadovic D, Schneider-Axmann T, Ecker UK, Retz W, Rösler M, Falkai P.

Schizophr Res. 2008 Oct;105(1-3):252-61. doi: 10.1016/j.schres.2008.06.001. Epub 2008 Jul 14.

PMID:
18625547
16.

Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.

Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Daniele A, Ghirlanda S, Gainotti G, Tonali PA.

J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):555-9.

17.

Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.

Wobrock T, Hasan A, Malchow B, Wolff-Menzler C, Guse B, Lang N, Schneider-Axmann T, Ecker UK, Falkai P.

Psychopharmacology (Berl). 2010 Feb;208(3):353-63. doi: 10.1007/s00213-009-1736-8. Epub 2009 Dec 9.

18.

Alteration of cortical excitability in patients with fibromyalgia.

Mhalla A, de Andrade DC, Baudic S, Perrot S, Bouhassira D.

Pain. 2010 Jun;149(3):495-500. doi: 10.1016/j.pain.2010.03.009. Epub 2010 Mar 31.

PMID:
20356675
19.

Intracortical inhibition and facilitation are abnormal in Huntington's disease: a paired magnetic stimulation study.

Abbruzzese G, Buccolieri A, Marchese R, Trompetto C, Mandich P, Schieppati M.

Neurosci Lett. 1997 Jun 6;228(2):87-90.

PMID:
9209105
20.

A GABBR2 gene variant modifies pathophysiology in Huntington's disease.

Philpott AL, Fitzgerald PB, Bailey NW, Churchyard A, Georgiou-Karistianis N, Cummins TD.

Neurosci Lett. 2016 May 4;620:8-13. doi: 10.1016/j.neulet.2016.03.038. Epub 2016 Mar 23.

PMID:
27033668

Supplemental Content

Support Center